Aldafermin reduces hydrophobic bile acids in a 24-week, randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis
Publication
, Conference
Sanyal, A; Ling, L; Neff, G; Guy, C; Bashir, M; Paredes, A; Frias, J; Younes, ZH; Trotter, JF; Gunn, NT; Moussa, S; Kohli, A; Nelson, K ...
Published in: JOURNAL OF HEPATOLOGY
2021
Duke Scholars
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
2021
Volume
75
Start / End Page
S616 / S617
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanyal, A., Ling, L., Neff, G., Guy, C., Bashir, M., Paredes, A., … Harrison, S. (2021). Aldafermin reduces hydrophobic bile acids in a 24-week, randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S616–S617).
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
2021
Volume
75
Start / End Page
S616 / S617
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences